SS&C Intralinks Success Stories
We’ve helped clients in nearly every country and industry throughout the world with secure innovative, productivity-driving solutions for high-value M&A, debt capital markets and banking transactions.
Here are just a few of our recent success stories. We’d love to add your brand to our hall of fame.
USD 1.1 billion
Teva Pharmaceutical Industries,
the Israel-based world leader in generic pharmaceuticals, used Intralinks to divest its PARAGARD® intrauterine device business to CooperSurgical for USD 1.1 billion.
the Israel-based world leader in generic pharmaceuticals, used Intralinks to divest its PARAGARD® intrauterine device business to CooperSurgical for USD 1.1 billion.
USD 1.1 billion
NeuroDerm,
an Israel-based pharmaceutical firm developing next-generation treatments for central nervous system disorders, used Intralinks for its acquisition by Mitsubishi Tanabe Pharma Corporation for USD 1.1 billion.
an Israel-based pharmaceutical firm developing next-generation treatments for central nervous system disorders, used Intralinks for its acquisition by Mitsubishi Tanabe Pharma Corporation for USD 1.1 billion.
USD 675 million
Teva Pharmaceutical Industries,
the Israel-based world leader in generic pharmaceuticals, used Intralinks to divest its emergency contraception brands portfolio to Foundation Consumer Healthcare for USD 675 million.
the Israel-based world leader in generic pharmaceuticals, used Intralinks to divest its emergency contraception brands portfolio to Foundation Consumer Healthcare for USD 675 million.
€5.7 billion
STADA Arzneimittel,
a German, listed pharmaceutical and healthcare company, used Intralinks for its acquisition by Bain Capital and Cinven Partners for €5.7 billion.
a German, listed pharmaceutical and healthcare company, used Intralinks for its acquisition by Bain Capital and Cinven Partners for €5.7 billion.